Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.

Acta neurologica Scandinavica - 1 Sept 2018

Hong Y, Li H-F, Romi F, Skeie G O, Gilhus N E

Abstract excerpt

OBJECTIVES: Myasthenia gravis (MG) represents a spectrum of clinical subtypes with differences in disease mechanisms and treatment response. MG with muscle-specific tyrosine kinase (MuSK) antibodies accounts for 1%-10% of all MG patients. We conducted a meta-analysis to evaluate the association between HLA genes and MuSK-MG susceptibility. SUBJECTS AND METHODS: Studies were searched in Pubmed, EMBASE database and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Gene Frequency
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Haplotypes

Share to Histocompatibility Antigens Class II

Share to Myasthenia Gravis

Share to Receptor Protein-Tyrosine Kinases

Share to Receptors, Cholinergic

Source

Identifiers

PMID: 29736936
DOI: 10.1111/ane.12951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.PMID 29736936Read ↗

Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.Semantic proximity Read ↗

Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.Semantic proximity Read ↗

Correlation Between the Prevalence of Myasthenia Gravis and the Frequency of Class II Human Leucocyte Antigen Alleles in Various Geographical Locations Around the WorldSemantic proximity Read ↗

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read ↗

Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.Semantic proximity Read ↗

HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort.Semantic proximity Read ↗

HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patientsSemantic proximity Read ↗

The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.Semantic proximity Read ↗

The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.Semantic proximity Read ↗

Genetic basis of myasthenia gravis - a comprehensive review.Semantic proximity Read ↗

The epidemiology of myasthenia gravis.Semantic proximity Read ↗

The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.